Lee J. Carter
- Democratic
Primary
Health insurance; cost-sharing payments for prescription insulin drugs. Prohibits health insurance companies and other carriers from setting an amount exceeding $50 per 30-day supply that a covered person is required to pay at the point of sale in order to receive a covered prescription insulin drug. The measure also prohibits a provider contract between a carrier or its pharmacy benefits manager and a pharmacy from containing a provision (i) authorizing the carrier's pharmacy benefits manager or the pharmacy to charge, (ii) requiring the pharmacy to collect, or (iii) requiring a covered person to make a cost-sharing payment for a covered prescription insulin drug in an amount that exceeds such limitation. This bill incorporates HB 1403.
Health insurance; cost-sharing payments for prescription insulin drugs. Prohibits health insurance companies and other carriers from setting an amount exceeding $30 per 30-day supply that a covered person is required to pay at the point of sale in order to receive a covered prescription insulin drug. The measure also prohibits a provider contract between a carrier or its pharmacy benefits manager and a pharmacy from containing a provision (i) authorizing the carrier's pharmacy benefits manager or the pharmacy to charge, (ii) requiring the pharmacy to collect, or (iii) requiring a covered person to make a cost-sharing payment for a covered prescription insulin drug in an amount that exceeds such limitation. This bill incorporates HB 1403.
Health insurance; cost-sharing payments for prescription insulin drugs. Prohibits health insurance companies and other carriers from setting an amount exceeding $30 per 30-day supply that a covered person is required to pay at the point of sale in order to receive a covered prescription insulin drug. The measure also prohibits a provider contract between a carrier or its pharmacy benefits manager and a pharmacy from containing a provision (i) authorizing the carrier's pharmacy benefits manager or the pharmacy to charge, (ii) requiring the pharmacy to collect, or (iii) requiring a covered person to make a cost-sharing payment for a covered prescription insulin drug in an amount that exceeds such limitation. This bill incorporates HB 1403.
Approved by Governor-Chapter 881 (effective 7/1/20)
Governor's Action Deadline 11:59 p.m., April 11, 2020
Enrolled Bill communicated to Governor on March 17, 2020
Impact statement from SCC (HB66ER)
Signed by Speaker
Enrolled
Signed by President
Engrossed by Senate as amended
Committee amendment agreed to
Read third time
Reading of amendment waived
VOTE: Adoption (88-Y 4-N)
Senate amendment agreed to by House (88-Y 4-N)
Passed Senate with amendment (24-Y 16-N)
Constitutional reading dispensed (40-Y 0-N)
Reported from Commerce and Labor with amendment (9-Y 6-N)
Impact statement from SCC (HB66H1)
Constitutional reading dispensed
Referred to Committee on Commerce and Labor
Read third time and passed House (98-Y 1-N)
VOTE: Passage (98-Y 1-N)
Engrossed by House - committee substitute HB66H1
Read second time
Committee substitute agreed to 20107156D-H1
Passed by temporarily
Read first time
Incorporates HB1403 (Leftwich)
Reported from Labor and Commerce with substitute (17-Y 1-N)
Committee substitute printed 20107156D-H1
Impact statement from SCC (HB66)
Subcommittee recommends reporting (4-Y 2-N)
Assigned L & C sub: Subcommittee #2
Referred to Committee on Labor and Commerce
Prefiled and ordered printed; offered 01/08/20 20100840D
| Bill Text Versions | Format |
|---|---|
| Impact statement from SCC (HB66) | HTML |
| Engrossed by House - committee substitute HB66H1 | HTML |
| Bill text as passed House and Senate (HB66ER) | HTML |
| Acts of Assembly Chapter text (CHAP0881) | HTML |
| Document | Format |
|---|---|
| Amendment: HB66ASE | HTML |
| Amendment: HB66AS | HTML |
Data on Open States is updated periodically throughout the day from the official website of the Virginia General Assembly.
If you notice any inconsistencies with these official sources, feel free to file an issue.